Virax Biolabs Group Ltd (VRAX) — research page
US · us-cm-kg/NASDAQ/VRAX · as of 2026-11-08
Identity and listing
The issuer is Virax Biolabs Group Ltd, listed on NASDAQ under ticker VRAX. The ISIN is not on the record and the LEI is not on the record. The security type is Non-operating entity type (other). The segment is not on the record. The sector is 2835 In Vitro & In Vivo Diagnostic Substances. The jurisdiction is Cayman Islands. The issuer is listed and not halted.
| field | value | source · read date |
|---|---|---|
| name | Virax Biolabs Group Ltd | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | VRAX | source · 2026-11-08 |
| ISIN | not on the record | |
| LEI | not on the record | |
| security type | Non-operating entity type (other) | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2835 In Vitro & In Vivo Diagnostic Substances | source · 2026-11-08 |
| jurisdiction | Cayman Islands | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 39 filings in the twelve months to 2026-11-08, across 33 filing days. The median gap between filing days is 8.0 days. The latest filing is dated 2026-10-29 and is of type results, 10 days before the record date. The NASDAQ median gap between filing days is 6.0 days, with a median of 52 filings and a median latency of 5.0 days. The sector median gap between filing days is 6.5 days, with a median of 61 filings and a median latency of 4 days.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 39 | 8 | 10 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2835 In Vitro & In Vivo Diagnostic Substances (19 issuers) | 61 | 6.5 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-29 | results | 6-K | 6-K — 6-K |
| 2026-10-21 | directors_dealings | 3 | 3 — 3 |
| 2026-10-09 | results | 6-K | 6-K — 6-K |
| 2026-09-10 | prospectus | 424B3 | 424B3 — 424B3 |
| 2026-09-04 | results | 6-K | 6-K — 6-K |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is not on the record, and the auditor's location is not on the record. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change lines. The domicile change is not on the record. The segment move is not on the record. The issuer is listed and not halted.
Orderability
The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
One research house is named on the issuer's own investor-relations page: H.C. Wainwright & Co.
| research house | analyst | source · read date |
|---|---|---|
| H.C. Wainwright & Co. | Yi Chen, Ph.D. CFA | issuer page · 2026-11-11 |
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The record holds the issuer's sealed years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.
Sources
7 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://data.sec.gov/submissions/CIK0001885827.json (identity.jurisdiction)
- 10.3
- https://mcp.us-cm-kg.ai/events/NASDAQ/VRAX (the disclosure lines)
- 10.4
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.5
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.6
- https://ir.viraxbiolabs.com/financial-information/analyst-coverage (coverage)
- 10.7
- https://mcp.us-cm-kg.ai/record/NASDAQ/VRAX (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"ticker":"VRAX","exchange":"NASDAQ"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:37deb93c0a69cf2c.